EFX.NYSEEquifax INC

Form 4: Equifax Executive Jamil Farshchi Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Equifax EVP, CISO & Acting CTO Jamil Farshchi exercised stock options and sold shares of common stock on November 26, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • Jamil Farshchi, an executive at Equifax, exercised stock options to acquire 9,171 shares at $127.37 and 5,545 shares at $138.45 on November 26, 2024.
  • Following the exercise of these options, Mr. Farshchi sold 14,716 shares at $260.39 on the same day.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 27, 2024.
  • After these transactions, Mr. Farshchi beneficially owns 34,632 shares of Equifax common stock.
  • The reported holdings include accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock transactions by an executive. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to executive stock option exercises and sales. It is common for executives to use 10b5-1 plans to manage their stock transactions and avoid accusations of insider trading.

Comparison to Industry Standards

  • The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies, including Equifax's competitors such as Experian and TransUnion.
  • The exercise of stock options and subsequent sale of shares is a common form of executive compensation and wealth management.
  • The prices at which the options were exercised and shares were sold are within the typical range for such transactions.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they represent a small portion of the total outstanding shares.
  • The transactions do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
02/22/2022Date the stock options were granted.
08/27/2024Date the Rule 10b5-1 trading plan was adopted.
11/26/2024Date of stock option exercise and share sale.
11/27/2024Date of filing the Form 4.
02/22/2025Expiration date of the stock options.

Keywords

Equifax, stock options, insider trading, Form 4, Rule 10b5-1, executive compensation, share sale, Jamil Farshchi

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.